Clinical Trial Update: Characterization of Arrhythmia Substrate to Ablate Persistent Atrial Fibrillation [NA]

View source ↗

Summary

A clinical trial update indicates a study to characterize arrhythmia substrate for ablation of persistent atrial fibrillation is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Fibrillation

Snippet

Sponsor: Ottawa Heart Institute Research Corporation | Conditions: Atrial Fibrillation | NA | Status: RECRUITING